Parathyroid hormone-independent regulation of 1,25(OH)2D in response to inhibition of bone resorption
- 1 March 1988
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 254 (3) , E260-E264
- https://doi.org/10.1152/ajpendo.1988.254.3.e260
Abstract
Both plasma level of 1,25-dihydroxyvitamin D [1,25(OH)2D] and intestinal Ca absorption increase after biphosphonate-induced inhibition of bone resorption. Parathyroid hormone (PTH) has been considered a key mediating element of this homeostatic response. In the present work, the role of PTH was assessed by studying the influence of 1-hydroxypentane-1,1-bisphosphonate (HPeBP) on vitamin D and Ca metabolism in both intact and thyroparathyroidectomized (TPTX) rats. In intact rats, HPeBP given at 0.1 mg P/kg body wt sc for 10 days strongly inhibited bone resorption without affecting bone formation. This effect was associated with a marked stimulation of intestinal Ca absorption and Ca balance. In this condition, HPeBP caused a marked rise in plasma 1.25(OH)2D without affecting the level of 25-hydroxyvitamin D. In TPTX rats, HPeBP given at same dose also inhibited bone resorption and enhanced plasma 1,25(OH)2D, intestinal Ca absorption and Ca balance. In summary, this study shows that bisphosphonates such as HPeBP with prevailing inhibitory activity on bone resorption induce a marked stimulation of both 1,25(OH)2D production and intestinal Ca absorption. This homeostatic response is not attenuated after PTH removal. Thus, as previously shown for the response to low Ca diet, PTH does not appear to be an essential mediating factor for stimulating 1,25(OH)2D production in response to an increase in bone mineral retention.This publication has 25 references indexed in Scilit:
- In vitro modulation of renal 25-hydroxyvitamin D3 metabolism by vitamin D3 metabolites and calciumArchives of Biochemistry and Biophysics, 1983
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.Journal of Clinical Investigation, 1979
- Effects of Calcium Intake and Renal Function on Plasma Immunoreactive Parathyroid Hormone Levels in RatsHormone and Metabolic Research, 1978
- Adaptation of intestinal calcium absorption: Parathyroid hormone and vitamin D metabolismArchives of Biochemistry and Biophysics, 1978
- A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasmaArchives of Biochemistry and Biophysics, 1976
- The ionic control of 1,25-dihydroxyvitamin D3 production in isolated chick renal tubules.Journal of Clinical Investigation, 1975
- Inhibition of vitamin D metabolism by ethane-1-hydroxy-1, 1-diphosphonateArchives of Biochemistry and Biophysics, 1974
- A competitive protein-binding assay for 25-hydroxy-cholecalciferol and 25-hydroxyergocalciferol in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1974